COCP

Conviction 10HealthcareScan · Thu, Jun 25, 2026

COCP$1.02-3.33%

ResistanceSupportVol 14

Vol MA14 87.51K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Cocrystal Pharma, Inc.PHARMACEUTICAL PREPARATIONSwww.cocrystalpharma.com ↗

Price1.02

Change-3.33%

Gap+0.48%

Rel volume0.20×

Avg volume102.9K

Avg $ vol106.15K

SMA 201.03

SMA 501.21

SMA 2001.13

Price vs 50-16.28%

Price vs 200-9.87%

MA stackmixed

50/200 cross—

Supertrenddown · 1.17

RSI (14)42

MACD hist0.01

MACD crossbull · 4d

Stoch %K / %D54 / 60

ADX (14)19

+DI / −DI17 / 17

RSI divergenceBullish

MACD divergenceBullish

ATR %+6.61%

ADR %6.14%

52w high1.94

52w low0.8602

From 52w high-47.68%

Above 52w low+18.00%

New 52w highNo

SqueezeOff

Bollinger width19.29%

%B0.44

Donchian pos29.37%

Donchian high1.20

Donchian low0.9400

AVWAP (52w high)1.68

vs AVWAP high-39.53%

AVWAP (52w low)1.60

vs AVWAP low-36.52%

OBV trendDown

Chaikin MF (20)-0.29

Today vs 20d0.20×

Avg vol (14d)87.51K

Avg vol (20d)102.9K

Avg $ vol (20d)106.15K

Market cap13.99M

RS 3m (vs SPY)-13.20%

RS 6m (vs SPY)-1.68%

RS line new highNo

Trend template0/8

Technical rank33.7

1 week+4.49%

1 month-10.18%

3 months-6.02%

6 months+3.49%

1 year-34.52%

YTD+2.24%

P/E-1.58

P/B3.40

P/S6.95

P/FCF-1.71

EPS-0.7800

Div yield—

ROE-214.55%

ROA-118.92%

Debt/Eq12.17

Current2.66

EV/EBITDA—

Gross margin358.57%

Net margin-438.48%

Rev growth0.00%

EPS growth49.55%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value57.07M

Revenue489K

Net income-2.3M

Gross profit1.11M

Free cash flow-8.2M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out13.79M

Employees10

ListedTue, Apr 1, 2008

Free float10.27M

Float %74.5%

Short interest143.17K

Days to cover1.1d

Short volume41.3%

Squeeze score9 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction10 / 100

Pattern quality—

Tech rank33.7 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.37

Support0.9433

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in COCP

All disclosures →

No recent disclosed trades by Congress in COCP. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in COCP · 1 buy

Insider	Side	Shares	Value	Traded	Filed
SAPIRSTEIN JAMES Chief Executive Officer · Stock Options (Right to Buy) · 2026-06-03	Grant	235K	$0	2026-06-03	2026-06-03

SEC filings

EDGAR filings in COCP · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.